FDA NDC Directory · JSON-LD · Markdown

POLIVY

NDC 50242-103 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namepolatuzumab vedotin
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA761121
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsPOLATUZUMAB VEDOTIN (30 mg/1.88mL)
Marketing started20190610
Package count1

External sources

Source: openFDA. Public-domain (CC0).